Trial Outcomes & Findings for Nurse-led Case Management for Diabetes and Cardiovascular Disease Patients With Depression (NCT NCT00468676)

NCT ID: NCT00468676

Last Updated: 2014-05-02

Results Overview

A scaled marginal model approach was used to jointly describe the four 12 month outcomes (SCL-20, HbA1c, systolic BP, LDL: all data submitted as Outcome Measures #2-5 below) and allowed use to test for a primary effect of the intervention among outcomes, scaling each outcome by its standard error, so the intervention effects could be interpreted as effect sizes.The model was estimated by iterating between estimation of the covariance associated with the outcomes and generalized-estimating equation estimation of scaled outcomes. Effect size is estimated as Cohen d effect size that was use for the depression outcome is the difference in change from baseline to 12 months in the intervention and usual care groups divided by the pooled base line standard deviation. Thus, a d of 0.25 indicates that one-quarter of a standard deviation separates the two means. Cohen has suggested that an effect size of 0.20 would be considered small, 0.50 medium and 0.80 large.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

214 participants

Primary outcome timeframe

Baseline to 12 months

Results posted on

2014-05-02

Participant Flow

Participants were recruited from may 2007 to october 2009 from 14 primary care clinics of Group Health Cooperative in Washington State

Exclusion criteria: terminal illness, residence in long-term care facility, bipolar/schizophrenia, mental confusion suggesting dementia, pregnancy/breast-feeding, use of antipsychotic/mood stabilizer med, severe hearing loss, planned bariatric surgery within 3 months, ongoing psychiatric care

Participant milestones

Participant milestones
Measure
Usual Care
Patients in usual care arm were advised to consult with their primary care physician to receive care for depression and for diabetes, coronary artery disease or both. With the patient's permission their primary care physician was notified about their PHQ-9 (Patient Health Questionnaire 9) score of 10 or greater and poor medical disease control. In addition primary care doctors received laboratory results at baseline, 6 and 12 months regarding HbA1c and at baseline and 12 months on fasting LDL
Care Management Intervention
Case management intervention: patients assigned to care management received intervention visits with a medical nurse supervised weekly by both a psychiatrist and primary care doctor. Nurses provided psychoeducation, motivational interviewing, behavioral activation and problem solving and carefully tracked medications, side effects, PHQ-9 (Patient Health Questionnaire 9) scores and blood pressure and lab results. Using a registry the medical supervisors recommended changes in medications that the nurse communicated to the patient's individual primary care doctor (who wrote all prescriptions). Nurses also worked with the patient to set self care goals regarding health behaviors such as increasing exercise or improving diet
Overall Study
STARTED
108
106
Overall Study
COMPLETED
92
94
Overall Study
NOT COMPLETED
16
12

Reasons for withdrawal

Reasons for withdrawal
Measure
Usual Care
Patients in usual care arm were advised to consult with their primary care physician to receive care for depression and for diabetes, coronary artery disease or both. With the patient's permission their primary care physician was notified about their PHQ-9 (Patient Health Questionnaire 9) score of 10 or greater and poor medical disease control. In addition primary care doctors received laboratory results at baseline, 6 and 12 months regarding HbA1c and at baseline and 12 months on fasting LDL
Care Management Intervention
Case management intervention: patients assigned to care management received intervention visits with a medical nurse supervised weekly by both a psychiatrist and primary care doctor. Nurses provided psychoeducation, motivational interviewing, behavioral activation and problem solving and carefully tracked medications, side effects, PHQ-9 (Patient Health Questionnaire 9) scores and blood pressure and lab results. Using a registry the medical supervisors recommended changes in medications that the nurse communicated to the patient's individual primary care doctor (who wrote all prescriptions). Nurses also worked with the patient to set self care goals regarding health behaviors such as increasing exercise or improving diet
Overall Study
Lost to Follow-up
14
11
Overall Study
Death
2
1

Baseline Characteristics

Nurse-led Case Management for Diabetes and Cardiovascular Disease Patients With Depression

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Usual Care
n=108 Participants
Patients in usual care arm were advised to consult with their primary care physician to receive care for depression and for diabetes, coronary artery disease or both. With the patient's permission their primary care physician was notified about their PHQ-9 score of 10 or greater and poor medical disease control. In addition primary care doctors received laboratory results at baseline, 6 and 12 months regarding HbA1c and at baseline and 12 months on fasting LDL
Care Management Intervention
n=106 Participants
Case management intervention: patients assigned to care management received intervention visits with a medical nurse supervised weekly by both a psychiatrist and primary care doctor. Nurses provided psychoeducation, motivational interviewing, behavioral activation and problem solving and carefully tracked medications, side effects, PHQ-9 scores and blood pressure and lab results. Using a registry the medical supervisors recommended changes in medications that the nurse communicated to the patient's individual primary care doctor (who wrote all prescriptions). Nurses also worked with the patient to set self care goals regarding health behaviors such as increasing exercise or improving diet
Total
n=214 Participants
Total of all reporting groups
Age, Categorical
<=18 years
1 Participants
n=99 Participants
0 Participants
n=107 Participants
1 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
82 Participants
n=99 Participants
81 Participants
n=107 Participants
163 Participants
n=206 Participants
Age, Categorical
>=65 years
25 Participants
n=99 Participants
25 Participants
n=107 Participants
50 Participants
n=206 Participants
Age, Continuous
56.3 years
STANDARD_DEVIATION 12.1 • n=99 Participants
57.4 years
STANDARD_DEVIATION 10.5 • n=107 Participants
56.8 years
STANDARD_DEVIATION 11.3 • n=206 Participants
Sex: Female, Male
Female
60 Participants
n=99 Participants
51 Participants
n=107 Participants
111 Participants
n=206 Participants
Sex: Female, Male
Male
48 Participants
n=99 Participants
55 Participants
n=107 Participants
103 Participants
n=206 Participants
Region of Enrollment
United States
108 participants
n=99 Participants
106 participants
n=107 Participants
214 participants
n=206 Participants

PRIMARY outcome

Timeframe: Baseline to 12 months

Population: This was an intent to treat analysis of the 12 month SCL-20, HbA1c, LDL and systolic blood pressure outcomes

A scaled marginal model approach was used to jointly describe the four 12 month outcomes (SCL-20, HbA1c, systolic BP, LDL: all data submitted as Outcome Measures #2-5 below) and allowed use to test for a primary effect of the intervention among outcomes, scaling each outcome by its standard error, so the intervention effects could be interpreted as effect sizes.The model was estimated by iterating between estimation of the covariance associated with the outcomes and generalized-estimating equation estimation of scaled outcomes. Effect size is estimated as Cohen d effect size that was use for the depression outcome is the difference in change from baseline to 12 months in the intervention and usual care groups divided by the pooled base line standard deviation. Thus, a d of 0.25 indicates that one-quarter of a standard deviation separates the two means. Cohen has suggested that an effect size of 0.20 would be considered small, 0.50 medium and 0.80 large.

Outcome measures

Outcome measures
Measure
Effect Size of Invervention Group to Standard Care
n=214 Participants
This was an intent to treat analysis calculating the intervention effect size of the 12 month SCL-20, HbA1c, LDL and systolic blood pressure outcomes combined
Care Management Intervention
Case management intervention: patients assigned to care management received intervention visits with a medical nurse supervised weekly by both a psychiatrist and primary care doctor. Nurses provided psychoeducation, motivational interviewing, behavioral activation and problem solving and carefully tracked medications, side effects, PHQ-9 scores and blood pressure and lab results. Using a registry the medical supervisors recommended changes in medications that the nurse communicated to the patient's individual primary care doctor (who wrote all prescriptions). Nurses also worked with the patient to set self care goals regarding health behaviors such as increasing exercise or improving diet
Combined Effect of Intervention on SCL-20, Systolic Blood Pressure, LDL and HbA1c
-1.57 unitless
95% Confidence Interval 0.66 • Interval -2.12 to -1.02

PRIMARY outcome

Timeframe: Measured at Baseline, 6 Months, 12 months

Population: This was an intent to treat analysis of the 12 month SCL-20, HbA1c, LDL and systolic blood pressure outcomes

SCL-20 is a 20 question checklist in which items are averaged to yield a potential score of 0 to 4 with higher scores indicating more severe depression symptoms. For the Primary Outcome (Outcome Measure #1 above), a scaled marginal model approach was used to jointly describe the four 12 month outcomes (SCL-20, HbA1c, systolic BP, LDL) and allowed use to test for a primary effect of the intervention among outcomes, scaling each outcome by its standard error, so the intervention effects could be interpreted as effect sizes.

Outcome measures

Outcome measures
Measure
Effect Size of Invervention Group to Standard Care
n=106 Participants
This was an intent to treat analysis calculating the intervention effect size of the 12 month SCL-20, HbA1c, LDL and systolic blood pressure outcomes combined
Care Management Intervention
n=105 Participants
Case management intervention: patients assigned to care management received intervention visits with a medical nurse supervised weekly by both a psychiatrist and primary care doctor. Nurses provided psychoeducation, motivational interviewing, behavioral activation and problem solving and carefully tracked medications, side effects, PHQ-9 scores and blood pressure and lab results. Using a registry the medical supervisors recommended changes in medications that the nurse communicated to the patient's individual primary care doctor (who wrote all prescriptions). Nurses also worked with the patient to set self care goals regarding health behaviors such as increasing exercise or improving diet
Symptom Checklist-20 Score at Baseline, 6 Months and 12 Months
SCL-20 at Baseline
1.65 scores on a scale
Standard Deviation 0.60
1.74 scores on a scale
Standard Deviation 0.59
Symptom Checklist-20 Score at Baseline, 6 Months and 12 Months
SCL-20 at 6 mos
1.26 scores on a scale
Standard Deviation 0.72
0.84 scores on a scale
Standard Deviation 0.68
Symptom Checklist-20 Score at Baseline, 6 Months and 12 Months
SCL-20 at 12 mos
1.14 scores on a scale
Standard Deviation 0.66
0.83 scores on a scale
Standard Deviation 0.68

PRIMARY outcome

Timeframe: Measured at Baseline, 6 Months, 12 months

Population: This was an intent to treat analysis of the 12 month SCL-20, HbA1c, LDL and systolic blood pressure outcomes

Systolic Blood Pressure was measured at Baseline, 6 months and 12 months For the Primary Outcome (Outcome Measure #1 above), a scaled marginal model approach was used to jointly describe the four 12 month outcomes (SCL-20, HbA1c, systolic BP, LDL) and allowed use to test for a primary effect of the intervention among outcomes, scaling each outcome by its standard error, so the intervention effects could be interpreted as effect sizes.

Outcome measures

Outcome measures
Measure
Effect Size of Invervention Group to Standard Care
n=106 Participants
This was an intent to treat analysis calculating the intervention effect size of the 12 month SCL-20, HbA1c, LDL and systolic blood pressure outcomes combined
Care Management Intervention
n=105 Participants
Case management intervention: patients assigned to care management received intervention visits with a medical nurse supervised weekly by both a psychiatrist and primary care doctor. Nurses provided psychoeducation, motivational interviewing, behavioral activation and problem solving and carefully tracked medications, side effects, PHQ-9 scores and blood pressure and lab results. Using a registry the medical supervisors recommended changes in medications that the nurse communicated to the patient's individual primary care doctor (who wrote all prescriptions). Nurses also worked with the patient to set self care goals regarding health behaviors such as increasing exercise or improving diet
Systolic Blood Pressure at Baseline, 6 Months and 12 Months
Systolic Blood Pressure at Baseline
131.9 mmHg
Standard Deviation 17.0
135.7 mmHg
Standard Deviation 18.4
Systolic Blood Pressure at Baseline, 6 Months and 12 Months
Systolic Blood Pressure at 6 months
133.5 mmHg
Standard Deviation 20.4
131.9 mmHg
Standard Deviation 15.2
Systolic Blood Pressure at Baseline, 6 Months and 12 Months
Systolic Blood Pressure at 12 months
132.3 mmHg
Standard Deviation 17.4
131.0 mmHg
Standard Deviation 18.2

PRIMARY outcome

Timeframe: Measured at Baseline and 12 months

Population: This was an intent to treat analysis of the 12 month SCL-20, HbA1c, LDL and systolic blood pressure outcomes

LDL Cholesterol was measured at Baseline and 12 months For the Primary Outcome (Outcome Measure #1 above), a scaled marginal model approach was used to jointly describe the four 12 month outcomes (SCL-20, HbA1c, systolic BP, LDL) and allowed use to test for a primary effect of the intervention among outcomes, scaling each outcome by its standard error, so the intervention effects could be interpreted as effect sizes.

Outcome measures

Outcome measures
Measure
Effect Size of Invervention Group to Standard Care
n=106 Participants
This was an intent to treat analysis calculating the intervention effect size of the 12 month SCL-20, HbA1c, LDL and systolic blood pressure outcomes combined
Care Management Intervention
n=105 Participants
Case management intervention: patients assigned to care management received intervention visits with a medical nurse supervised weekly by both a psychiatrist and primary care doctor. Nurses provided psychoeducation, motivational interviewing, behavioral activation and problem solving and carefully tracked medications, side effects, PHQ-9 scores and blood pressure and lab results. Using a registry the medical supervisors recommended changes in medications that the nurse communicated to the patient's individual primary care doctor (who wrote all prescriptions). Nurses also worked with the patient to set self care goals regarding health behaviors such as increasing exercise or improving diet
LDL Cholesterol at Baseline and 12 Months
LDL cholesterol at 12 months
101.4 mg/dL
Standard Deviation 36.6
91.9 mg/dL
Standard Deviation 36.7
LDL Cholesterol at Baseline and 12 Months
LDL cholesterol at Baseline
109.4 mg/dL
Standard Deviation 36.7
106.8 mg/dL
Standard Deviation 35.4

PRIMARY outcome

Timeframe: Measured at Baseline, 6 months and 12 months

Population: This was an intent to treat analysis of the 12 month SCL-20, HbA1c, LDL and systolic blood pressure outcomes

Glycated hemoglobin (HbA1c) was measured at Baseline, 6 months and 12 months For the Primary Outcome (Outcome Measure #1 above), a scaled marginal model approach was used to jointly describe the four 12 month outcomes (SCL-20, HbA1c, systolic BP, LDL) and allowed use to test for a primary effect of the intervention among outcomes, scaling each outcome by its standard error, so the intervention effects could be interpreted as effect sizes.

Outcome measures

Outcome measures
Measure
Effect Size of Invervention Group to Standard Care
n=106 Participants
This was an intent to treat analysis calculating the intervention effect size of the 12 month SCL-20, HbA1c, LDL and systolic blood pressure outcomes combined
Care Management Intervention
n=105 Participants
Case management intervention: patients assigned to care management received intervention visits with a medical nurse supervised weekly by both a psychiatrist and primary care doctor. Nurses provided psychoeducation, motivational interviewing, behavioral activation and problem solving and carefully tracked medications, side effects, PHQ-9 scores and blood pressure and lab results. Using a registry the medical supervisors recommended changes in medications that the nurse communicated to the patient's individual primary care doctor (who wrote all prescriptions). Nurses also worked with the patient to set self care goals regarding health behaviors such as increasing exercise or improving diet
Glycated Hemoglobin (HbA1c) at Baseline, 6 Months and 12 Months
Glycated Hemoglobin (HbA1c) at Baseline
8.04 percent glycated hemoglobin
Standard Deviation 1.87
8.14 percent glycated hemoglobin
Standard Deviation 2.03
Glycated Hemoglobin (HbA1c) at Baseline, 6 Months and 12 Months
Glycated Hemoglobin (HbA1c) at 6 months
7.87 percent glycated hemoglobin
Standard Deviation 1.93
7.42 percent glycated hemoglobin
Standard Deviation 1.32
Glycated Hemoglobin (HbA1c) at Baseline, 6 Months and 12 Months
Glycated Hemoglobin (HbA1c) at 12 months
7.81 percent glycated hemoglobin
Standard Deviation 1.90
7.33 percent glycated hemoglobin
Standard Deviation 1.21

SECONDARY outcome

Timeframe: Measured at Months 6, 12 months

Disability was measured by the Sheehan Disability scale which measures the extent to which health interferes with social, vocational and familial functioning each on a 0 to 10 Likert scale where 0 is "not at all" and 10 is "extremely". This scale consists of 3 items which are averaged together to create the average disability score, which ranges from 0 to 10.

Outcome measures

Outcome measures
Measure
Effect Size of Invervention Group to Standard Care
n=108 Participants
This was an intent to treat analysis calculating the intervention effect size of the 12 month SCL-20, HbA1c, LDL and systolic blood pressure outcomes combined
Care Management Intervention
n=106 Participants
Case management intervention: patients assigned to care management received intervention visits with a medical nurse supervised weekly by both a psychiatrist and primary care doctor. Nurses provided psychoeducation, motivational interviewing, behavioral activation and problem solving and carefully tracked medications, side effects, PHQ-9 scores and blood pressure and lab results. Using a registry the medical supervisors recommended changes in medications that the nurse communicated to the patient's individual primary care doctor (who wrote all prescriptions). Nurses also worked with the patient to set self care goals regarding health behaviors such as increasing exercise or improving diet
Functional Impairment
6-month follow-up
4.2 units on a scale
Standard Deviation 2.6
3.7 units on a scale
Standard Deviation 3.2
Functional Impairment
12-month follow-up
4.5 units on a scale
Standard Deviation 2.9
3.8 units on a scale
Standard Deviation 3.0

SECONDARY outcome

Timeframe: Cumulative outpatient costs over 24 months

Mean total outpatient costs for 2 years post baseline adjusted for age, gender and previous 12 months of outpatient costs

Outcome measures

Outcome measures
Measure
Effect Size of Invervention Group to Standard Care
n=108 Participants
This was an intent to treat analysis calculating the intervention effect size of the 12 month SCL-20, HbA1c, LDL and systolic blood pressure outcomes combined
Care Management Intervention
n=106 Participants
Case management intervention: patients assigned to care management received intervention visits with a medical nurse supervised weekly by both a psychiatrist and primary care doctor. Nurses provided psychoeducation, motivational interviewing, behavioral activation and problem solving and carefully tracked medications, side effects, PHQ-9 scores and blood pressure and lab results. Using a registry the medical supervisors recommended changes in medications that the nurse communicated to the patient's individual primary care doctor (who wrote all prescriptions). Nurses also worked with the patient to set self care goals regarding health behaviors such as increasing exercise or improving diet
Health Care Costs
21,513 US dollars
Standard Deviation 9201
20,918 US dollars
Standard Deviation 10,419

Adverse Events

Usual Care

Serious events: 2 serious events
Other events: 23 other events
Deaths: 0 deaths

Care Management Intervention

Serious events: 1 serious events
Other events: 27 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Usual Care
n=106 participants at risk;n=108 participants at risk
Treatment as usual Treatment as usual: Participants will attend 10 study visits and receive 4 follow-up phone calls over 24 months. During this time, participants will receive usual care.
Care Management Intervention
n=105 participants at risk;n=106 participants at risk
Care management intervention Nurse-led case management: The case management intervention will entail approximately 10 visits with a trained nurse at the clinic or by telephone. Participants in this group will receive educational materials about how to manage diabetes and/or heart disease and stress or depression. Nurses will also provide guidance and support in managing medications, phone calls to check participants' progress, and assistance in setting personal goals and in managing physical health problems and symptoms of depression or stress.
General disorders
Death
1.9%
2/108
0.94%
1/106

Other adverse events

Other adverse events
Measure
Usual Care
n=106 participants at risk;n=108 participants at risk
Treatment as usual Treatment as usual: Participants will attend 10 study visits and receive 4 follow-up phone calls over 24 months. During this time, participants will receive usual care.
Care Management Intervention
n=105 participants at risk;n=106 participants at risk
Care management intervention Nurse-led case management: The case management intervention will entail approximately 10 visits with a trained nurse at the clinic or by telephone. Participants in this group will receive educational materials about how to manage diabetes and/or heart disease and stress or depression. Nurses will also provide guidance and support in managing medications, phone calls to check participants' progress, and assistance in setting personal goals and in managing physical health problems and symptoms of depression or stress.
General disorders
Hosptializations
21.7%
23/106 • Number of events 23
25.7%
27/105 • Number of events 27

Additional Information

Dr Wayne Katon, Professor and Vice Chair

Dept Psychiatry, University of Washington Medical School

Phone: 206-543-7177

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place